/div>WHOs emergency use listing procedure assesses the quality, safety and efficacy of #COVID19 vaccines and is a prerequisite for #COVAX vaccine supply.
— World Health Organization (WHO) (@WHO) December 17, 2021
It also allows countries to expedite their own regulatory approval to import and administer COVID-19 vaccines. https://t.co/1sCdSMx7RF
Covovax receives @WHO approval for emergency use, strengthening our fight against #Covid_19. @Novavax @GaviSeth @gavi @gatesfoundation https://t.co/HHCgi1qCoR
— SerumInstituteIndia (@SerumInstIndia) December 17, 2021